MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • VistaGen Therapeutics (VSTA) Revolutionizes Drug Development And Testing 0 comments
    Apr 12, 2012 2:08 PM | about stocks: VTGN

    VistaGen Therapeutics is, in a sense, turning the world of drug development and testing upside down with its proprietary pluripotent stem cell technology platform called Human Clinical Trials in a Test Tube.

    VistaGen's stem cell technology is directed at once-promising drug candidates that had to be discontinued during development due to heart toxicity issues. Traditional toxicity testing of new drug candidates takes place in animal studies and human clinical trials during the final stages of development. Such testing suffers from a significant lack of accuracy in predicting future toxicity, and occurs well after significant resources have been invested to bring the drug along. The result too often represents a major financial loss to the developer, when toxicity problems are discovered. In addition, if the drug has already gone to market, the lives of patients can be jeopardized.

    Through the use of VistaGen's Human Clinical Trials in a Test Tube approach, stem-cell derived functional human heart cells can be used in highly accurate laboratory testing of new drug candidates, before the investment in further development or clinical trials. Such early-stage testing saves money and time, allowing the developer to make adjustments when and if problems are found. Moreover, previously withdrawn drug candidates can potentially be rescued through this efficient and cost-effective test tube approach, turning a major financial loss into a revenue-generating asset.

    For additional information, visit the company's website at www.VistaGen.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: VTGN
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.